Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Clinical trial NCT04951323 · UNKNOWN

Trial details

NCT number: NCT04951323
Sponsor: University of Liege
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (Covid19)Hematopoietic Neoplasms

Start date: 2021-03-22
Primary completion: 2022-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.